AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:38PM EDT. Market open.
| Previous close | 68.36 |
| Open | 68.19 |
| Bid | 68.37 x 600 |
| Ask | 68.44 x 600 |
| Day's range | 68.16 - 68.71 |
| 52-week range | 60.47 - 76.56 |
| Volume | |
| Avg. volume | 6,269,330 |
| Market cap | 212.086B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 35.81 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.45 (2.12%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | N/A |
- Zacks
Astrazeneca (AZN) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.
- Fool.co.uk
I don’t care how much FTSE bosses are paid as long as they make me rich!
Facing accusations of greed, the pay packages of FTSE CEOs are back in the headlines. But our writer takes a more relaxed view, on one condition. The post I don’t care how much FTSE bosses are paid as long as they make me rich! appeared first on The Motley Fool UK.
- Zacks
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
The FDA approves AstraZeneca's (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11 years.
© 2024 Yahoo. All rights reserved.